PDB Short entry for 2RHI HEADER TRANSCRIPTION/NUCLEAR PROTEIN 09-OCT-07 2RHI TITLE CRYSTAL STRUCTURE OF THE 3-MBT DOMAIN FROM HUMAN L3MBTL1 IN COMPLEX TITLE 2 WITH H1.5K27ME2 AT 1.66 ANGSTROM COMPND MOL_ID: 1; COMPND 2 MOLECULE: LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: REPEATS MBT-1, MBT-2, MBT-3; RESIDUES 197-526; COMPND 5 SYNONYM: L3, MBT-LIKE, L3, MBT PROTEIN HOMOLOG, H-L3, MBT PROTEIN, H- COMPND 6 L3, MBT, L3MBTL1; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: HISTONE H1.5; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: N-TERMINAL TAIL RESIDEUS 23-27; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: L3MBTL, KIAA0681, L3MBT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSSETA2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX4T3; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HUMANS KEYWDS BETA BARREL, PROTEIN-PEPTIDE COMPLEX, DIMETHYL-LYSINE, ALTERNATIVE KEYWDS 2 SPLICING, CHROMATIN REGULATOR, DNA-BINDING, METAL-BINDING, NUCLEUS, KEYWDS 3 REPRESSOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC- KEYWDS 4 FINGER, TRANSCRIPTION-NUCLEAR PROTEIN COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.LI,D.J.PATEL REVDAT 3 30-AUG-23 2RHI 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 2RHI 1 VERSN REVDAT 1 11-DEC-07 2RHI 0 JRNL AUTH H.LI,W.FISCHLE,W.WANG,E.M.DUNCAN,L.LIANG,S.MURAKAMI-ISHIBE, JRNL AUTH 2 C.D.ALLIS,D.J.PATEL JRNL TITL STRUCTURAL BASIS FOR LOWER LYSINE METHYLATION STATE-SPECIFIC JRNL TITL 2 READOUT BY MBT REPEATS OF L3MBTL1 AND AN ENGINEERED PHD JRNL TITL 3 FINGER. JRNL REF MOL.CELL V. 28 677 2007 JRNL REFN ISSN 1097-2765 JRNL PMID 18042461 JRNL DOI 10.1016/J.MOLCEL.2007.10.023 REMARK 2 REMARK 2 RESOLUTION. 1.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 54919 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 4490 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.66 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.72 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2800 REMARK 3 BIN FREE R VALUE : 0.2500 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 410 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2649 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 564 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.09 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.11 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.410 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTOPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2RHI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-OCT-07. REMARK 100 THE DEPOSITION ID IS D_1000044865. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-AUG-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0858 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56401 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.660 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 10.00 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : 0.06500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 31.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.80 REMARK 200 R MERGE FOR SHELL (I) : 0.46000 REMARK 200 R SYM FOR SHELL (I) : 0.46000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1OZ2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: L3MBTL1(197-526) (15 MG/ML IN 25 MM REMARK 280 TRIS-HCL, PH 8.0, 1 MM DTT) WAS PRE-INCUBATED WITH TWO-FOLD REMARK 280 MOLAR EXCESS OF H1.5(23-27)K27ME2 PEPTIDE. DROPS WERE PREPARED REMARK 280 BY MIXING 1 L COMPLEX SOLUTION WITH 1 L RESERVOIR SOLUTION (7% REMARK 280 PEG3350, 0.2 M NAAC PH 5.0). ROD-LIKE CRYSTALS USUALLY APPEAR REMARK 280 OVERNIGHT AND ARE READY FOR DATA COLLECTION AFTER TWO DAYS. REMARK 280 CRYSTALS WERE FLASH-FROZEN IN LIQUID NITROGEN WITH THE RESERVOIR REMARK 280 SOLUTION AUGMENTED WITH AN ADDITIONAL 30% PEG 400 AS REMARK 280 CRYOPROTECTANT PRIOR TO DATA COLLECTIOIN., VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 42.93200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.65900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.93200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.65900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 750 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 192 REMARK 465 SER A 193 REMARK 465 PRO A 194 REMARK 465 ASN A 195 REMARK 465 SER A 196 REMARK 465 PRO A 197 REMARK 465 ALA A 198 REMARK 465 THR A 199 REMARK 465 GLY A 200 REMARK 465 GLU A 201 REMARK 465 LYS A 202 REMARK 465 LYS A 203 REMARK 465 GLU A 204 REMARK 465 SER A 529 REMARK 465 SER A 530 REMARK 465 GLY A 531 REMARK 465 ARG A 532 REMARK 465 ILE A 533 REMARK 465 VAL A 534 REMARK 465 THR A 535 REMARK 465 ASP A 536 REMARK 465 LYS B 22 REMARK 465 ALA B 23 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 252 C - N - CA ANGL. DEV. = 9.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 251 64.31 -158.10 REMARK 500 ASP A 372 -124.23 54.74 REMARK 500 ASN A 452 -10.11 85.68 REMARK 500 LEU A 455 -167.91 -160.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2RHU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE 3-MBT REPEATS FROM HUMAN L3MBTL1 BOUND TO REMARK 900 DIMETHYL-LYSINE AND IN CHIMERA WITH HISTONE H3.3(28-34) REMARK 900 RELATED ID: 2RHX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE 3-MBT REPEATS FROM HUMAN L3MBTL1 BOUND TO REMARK 900 DIMETHYL-LYSINE REMARK 900 RELATED ID: 2RHY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE 3-MBT REPEATS FROM HUMAN L3MBTL1 BOUND TO REMARK 900 MONOMETHYL-LYSINE REMARK 900 RELATED ID: 2RHZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE 3-MBT REPEATS FROM HUMAN L3MBTL1 WITH REMARK 900 D355N POINT MUTATION REMARK 900 RELATED ID: 2RI2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE 3-MBT REPEATS FROM HUMAN L3MBTL1 WITH REMARK 900 D355A POINT MUTATION REMARK 900 RELATED ID: 2RI3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE 3-MBT REPEATS FROM HUMAN L3MBTL1 WITH REMARK 900 N358Q POINT MUTATION REMARK 900 RELATED ID: 2RI5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE 3-MBT REPEATS FROM HUMAN L3MBTL1 WITH REMARK 900 N358A POINT MUTATION DBREF 2RHI A 197 526 UNP Q9Y468 LMBTL_HUMAN 193 522 DBREF 2RHI B 22 26 UNP P16401 H15_HUMAN 23 27 SEQADV 2RHI GLY A 192 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHI SER A 193 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHI PRO A 194 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHI ASN A 195 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHI SER A 196 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHI VAL A 527 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHI ASP A 528 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHI SER A 529 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHI SER A 530 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHI GLY A 531 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHI ARG A 532 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHI ILE A 533 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHI VAL A 534 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHI THR A 535 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHI ASP A 536 UNP Q9Y468 EXPRESSION TAG SEQRES 1 A 345 GLY SER PRO ASN SER PRO ALA THR GLY GLU LYS LYS GLU SEQRES 2 A 345 CYS TRP SER TRP GLU SER TYR LEU GLU GLU GLN LYS ALA SEQRES 3 A 345 ILE THR ALA PRO VAL SER LEU PHE GLN ASP SER GLN ALA SEQRES 4 A 345 VAL THR HIS ASN LYS ASN GLY PHE LYS LEU GLY MET LYS SEQRES 5 A 345 LEU GLU GLY ILE ASP PRO GLN HIS PRO SER MET TYR PHE SEQRES 6 A 345 ILE LEU THR VAL ALA GLU VAL CYS GLY TYR ARG LEU ARG SEQRES 7 A 345 LEU HIS PHE ASP GLY TYR SER GLU CYS HIS ASP PHE TRP SEQRES 8 A 345 VAL ASN ALA ASN SER PRO ASP ILE HIS PRO ALA GLY TRP SEQRES 9 A 345 PHE GLU LYS THR GLY HIS LYS LEU GLN PRO PRO LYS GLY SEQRES 10 A 345 TYR LYS GLU GLU GLU PHE SER TRP SER GLN TYR LEU ARG SEQRES 11 A 345 SER THR ARG ALA GLN ALA ALA PRO LYS HIS LEU PHE VAL SEQRES 12 A 345 SER GLN SER HIS SER PRO PRO PRO LEU GLY PHE GLN VAL SEQRES 13 A 345 GLY MET LYS LEU GLU ALA VAL ASP ARG MET ASN PRO SER SEQRES 14 A 345 LEU VAL CYS VAL ALA SER VAL THR ASP VAL VAL ASP SER SEQRES 15 A 345 ARG PHE LEU VAL HIS PHE ASP ASN TRP ASP ASP THR TYR SEQRES 16 A 345 ASP TYR TRP CYS ASP PRO SER SER PRO TYR ILE HIS PRO SEQRES 17 A 345 VAL GLY TRP CYS GLN LYS GLN GLY LYS PRO LEU THR PRO SEQRES 18 A 345 PRO GLN ASP TYR PRO ASP PRO ASP ASN PHE CYS TRP GLU SEQRES 19 A 345 LYS TYR LEU GLU GLU THR GLY ALA SER ALA VAL PRO THR SEQRES 20 A 345 TRP ALA PHE LYS VAL ARG PRO PRO HIS SER PHE LEU VAL SEQRES 21 A 345 ASN MET LYS LEU GLU ALA VAL ASP ARG ARG ASN PRO ALA SEQRES 22 A 345 LEU ILE ARG VAL ALA SER VAL GLU ASP VAL GLU ASP HIS SEQRES 23 A 345 ARG ILE LYS ILE HIS PHE ASP GLY TRP SER HIS GLY TYR SEQRES 24 A 345 ASP PHE TRP ILE ASP ALA ASP HIS PRO ASP ILE HIS PRO SEQRES 25 A 345 ALA GLY TRP CYS SER LYS THR GLY HIS PRO LEU GLN PRO SEQRES 26 A 345 PRO LEU GLY PRO ARG GLU PRO SER SER ALA VAL ASP SER SEQRES 27 A 345 SER GLY ARG ILE VAL THR ASP SEQRES 1 B 5 LYS ALA THR LYS MLY MODRES 2RHI MLY B 26 LYS N-DIMETHYL-LYSINE HET MLY B 26 12 HET PG4 A 1 13 HET PEG A 2 7 HETNAM MLY N-DIMETHYL-LYSINE HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM PEG DI(HYDROXYETHYL)ETHER FORMUL 2 MLY C8 H18 N2 O2 FORMUL 3 PG4 C8 H18 O5 FORMUL 4 PEG C4 H10 O3 FORMUL 5 HOH *564(H2 O) HELIX 1 1 SER A 207 LYS A 216 1 10 HELIX 2 2 PRO A 221 PHE A 225 5 5 HELIX 3 3 GLN A 226 VAL A 231 1 6 HELIX 4 4 SER A 276 ASP A 280 5 5 HELIX 5 5 GLY A 294 GLY A 300 1 7 HELIX 6 6 LYS A 310 PHE A 314 5 5 HELIX 7 7 SER A 315 ARG A 324 1 10 HELIX 8 8 PRO A 329 PHE A 333 5 5 HELIX 9 9 ASP A 383 ASP A 387 5 5 HELIX 10 10 GLY A 401 GLY A 407 1 7 HELIX 11 11 ASP A 418 PHE A 422 5 5 HELIX 12 12 CYS A 423 GLY A 432 1 10 HELIX 13 13 PRO A 437 PHE A 441 5 5 HELIX 14 14 SER A 487 ASP A 491 5 5 HELIX 15 15 GLY A 505 GLY A 511 1 7 SHEET 1 A 5 PHE A 281 ASN A 284 0 SHEET 2 A 5 ARG A 267 PHE A 272 -1 N LEU A 270 O PHE A 281 SHEET 3 A 5 HIS A 251 CYS A 264 -1 N ALA A 261 O ARG A 269 SHEET 4 A 5 LYS A 243 ASP A 248 -1 N LEU A 244 O LEU A 258 SHEET 5 A 5 ILE A 290 HIS A 291 -1 O HIS A 291 N GLU A 245 SHEET 1 B 5 TYR A 388 CYS A 390 0 SHEET 2 B 5 ARG A 374 PHE A 379 -1 N PHE A 375 O CYS A 390 SHEET 3 B 5 ASN A 358 VAL A 371 -1 N SER A 366 O HIS A 378 SHEET 4 B 5 LYS A 350 ASP A 355 -1 N ALA A 353 O CYS A 363 SHEET 5 B 5 ILE A 397 HIS A 398 -1 O HIS A 398 N GLU A 352 SHEET 1 C 4 TYR A 388 CYS A 390 0 SHEET 2 C 4 ARG A 374 PHE A 379 -1 N PHE A 375 O CYS A 390 SHEET 3 C 4 ASN A 358 VAL A 371 -1 N SER A 366 O HIS A 378 SHEET 4 C 4 LEU A 410 THR A 411 1 O THR A 411 N VAL A 362 SHEET 1 D 5 PHE A 492 ASP A 495 0 SHEET 2 D 5 ARG A 478 PHE A 483 -1 N ILE A 481 O PHE A 492 SHEET 3 D 5 ILE A 466 VAL A 474 -1 N GLU A 472 O LYS A 480 SHEET 4 D 5 LYS A 454 VAL A 458 -1 N LEU A 455 O ALA A 469 SHEET 5 D 5 ILE A 501 HIS A 502 -1 O HIS A 502 N GLU A 456 LINK C LYS B 25 N MLY B 26 1555 1555 1.36 SITE 1 AC1 8 CYS A 278 ASP A 459 ARG A 461 TRP A 486 SITE 2 AC1 8 TYR A 490 HOH A 589 HOH A 635 HOH A 829 SITE 1 AC2 5 THR A 232 HIS A 233 LYS A 235 LYS A 509 SITE 2 AC2 5 HOH A 776 CRYST1 85.864 93.318 58.640 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011646 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010716 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017053 0.00000